<DOC>
	<DOCNO>NCT00500149</DOCNO>
	<brief_summary>The primary objective study assess time onset Vyvanse compare placebo , analog classroom measure Swanson , Kotkin , Agler , M. Flynn Pelham ( SKAMP ) deportment scale child ( age 6-12 ) diagnose Attention-Deficit/Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>A Classroom Study Assess Time Onset Vyvanse ( Lisdexamfetamine Dimesylate ) Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>1 . Subject male female age 612 year inclusive time consent . 2 . Females Childbearing Potential ( FOCP ) must negative serum beta Human Chorionic Gonadotropin ( HCG ) pregnancy test Screening negative urine pregnancy test Baseline agree comply applicable contraceptive requirement protocol . 3 . Primary diagnosis ADHD : combine subtype predominantly hyperactive impulsive subtype base detailed psychiatric evaluation . 4 . Subject baseline ADHDRSIV score â‰¥ 28 . 5 . Intelligent Quotient ( IQ ) score 80 Kaufman Brief Intelligence Test ( KBIT ) . 6 . Subject must able complete least Basic Test PERMP assessment . 1 . Subject current , control ( require restrict medication ) uncontrolled , comorbid psychiatric diagnosis significant symptom Post Traumatic Stress Disorder ( PTSD ) , psychosis , bipolar illness , pervasive developmental disorder , severe obsessive compulsive disorder , severe depressive severe anxiety disorder 2 . Subject Conduct Disorder . 3 . Subject document allergy , hypersensitivity intolerance amphetamine . 4 . Subject fail respond one adequate course ( dose duration ) amphetamine therapy . 5 . The subject recent history ( within past 6 month ) suspect substance abuse dependence disorder ( exclude nicotine ) accordance DSMIVTR criterion . 6 . Subject weigh less 50 pound ( 22.7kg ) . 7 . Subject significantly overweight 8 . Subject history seizure last two year ( exclusive febrile seizure ) , tic disorder , current diagnosis and/or family history Tourette 's Disorder . 9 . Subject report history abnormal thyroid function . 10 . Subject take another investigational drug take part clinical trial within last 30 day prior Screening . 11 . Subject known history structural cardiac abnormality , well condition ( ) may affect cardiac performance . 12 . Subject concurrent chronic acute illness ( severe allergic rhinitis infectious process require antibiotic ) , disability , condition might confound result safety assessments 13 . Subject take medication central nervous system ( CNS ) effect affect performance , sedate antihistamine decongestant sympathomimetics ( bronchodilator exclusionary ) . 14 . The female subject pregnant lactating . 15 . Subject well control current ADHD medication acceptable tolerability .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>